)
)
)
Italfarmaco Group
Focus for this conference is:
- In-licensing of late stage assets for markets mainly in EU in niche areas
- In-licensing of late stage assets with rare / orphan indications, especially in the neuromuscolar space for Europe and USA
- Out-licensing: R&D assets in the available geographies
Address
Cinisello Balsamo (Milano)Italy
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)